U54 CA198999/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2015	9
2016	17
2017	19
2018	26
2019	23
2020	25
2021	16
2022	8
2023	2
2024	0

1

Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval.

Hwang D, Ramsey JD, Kabanov AV. Hwang D, et al. Adv Drug Deliv Rev. 2020;156:80-118. doi: 10.1016/j.addr.2020.09.009. Epub 2020 Sep 24. Adv Drug Deliv Rev. 2020. PMID: 32980449 Free PMC article. Review.

2

Icaritin Exacerbates Mitophagy and Synergizes with Doxorubicin to Induce Immunogenic Cell Death in Hepatocellular Carcinoma.

Yu Z, Guo J, Hu M, Gao Y, Huang L. Yu Z, et al. ACS Nano. 2020 Apr 28;14(4):4816-4828. doi: 10.1021/acsnano.0c00708. Epub 2020 Mar 23. ACS Nano. 2020. PMID: 32188241

3

Nanoparticle Delivery of miR-122 Inhibits Colorectal Cancer Liver Metastasis.

Sendi H, Yazdimamaghani M, Hu M, Sultanpuram N, Wang J, Moody AS, McCabe E, Zhang J, Graboski A, Li L, Rojas JD, Dayton PA, Huang L, Wang AZ. Sendi H, et al. Cancer Res. 2022 Jan 1;82(1):105-113. doi: 10.1158/0008-5472.CAN-21-2269. Epub 2021 Nov 9. Cancer Res. 2022. PMID: 34753773 Free PMC article.

4

Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy.

Zhou J, Liu M, Sun H, Feng Y, Xu L, Chan AWH, Tong JH, Wong J, Chong CCN, Lai PBS, Wang HK, Tsang SW, Goodwin T, Liu R, Huang L, Chen Z, Sung JJ, Chow KL, To KF, Cheng AS. Zhou J, et al. Gut. 2018 May;67(5):931-944. doi: 10.1136/gutjnl-2017-314032. Epub 2017 Sep 22. Gut. 2018. PMID: 28939663 Free PMC article.

5

Two nanoformulations induce reactive oxygen species and immunogenetic cell death for synergistic chemo-immunotherapy eradicating colorectal cancer and hepatocellular carcinoma.

Guo J, Yu Z, Sun D, Zou Y, Liu Y, Huang L. Guo J, et al. Mol Cancer. 2021 Jan 6;20(1):10. doi: 10.1186/s12943-020-01297-0. Mol Cancer. 2021. PMID: 33407548 Free PMC article.

6

Nanotechnology in Radiation Oncology.

Sun B, Hagan CT 4th, Caster J, Wang AZ. Sun B, et al. Hematol Oncol Clin North Am. 2019 Dec;33(6):1071-1093. doi: 10.1016/j.hoc.2019.08.002. Epub 2019 Oct 1. Hematol Oncol Clin North Am. 2019. PMID: 31668207 Free PMC article. Review.

7

Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer.

Liu L, Wang Y, Miao L, Liu Q, Musetti S, Li J, Huang L. Liu L, et al. Mol Ther. 2018 Jan 3;26(1):45-55. doi: 10.1016/j.ymthe.2017.10.020. Epub 2017 Dec 5. Mol Ther. 2018. PMID: 29258739 Free PMC article.

8

Membrane-core nanoparticles for cancer nanomedicine.

Guo J, Huang L. Guo J, et al. Adv Drug Deliv Rev. 2020;156:23-39. doi: 10.1016/j.addr.2020.05.005. Epub 2020 May 22. Adv Drug Deliv Rev. 2020. PMID: 32450105 Free PMC article. Review.

9

Alternative tumour-specific antigens.

Smith CC, Selitsky SR, Chai S, Armistead PM, Vincent BG, Serody JS. Smith CC, et al. Nat Rev Cancer. 2019 Aug;19(8):465-478. doi: 10.1038/s41568-019-0162-4. Epub 2019 Jul 5. Nat Rev Cancer. 2019. PMID: 31278396 Free PMC article. Review.

10

Emerging Nano-/Microapproaches for Cancer Immunotherapy.

Mi Y, Hagan CT 4th, Vincent BG, Wang AZ. Mi Y, et al. Adv Sci (Weinh). 2019 Jan 13;6(6):1801847. doi: 10.1002/advs.201801847. eCollection 2019 Mar 20. Adv Sci (Weinh). 2019. PMID: 30937265 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

126 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

126 results

Results by year